epilepsy is one of the most common chronic disorders affecting individuals of all ages. a greater understanding of pathogenesis in epilepsy will likely provide the basis fundamental for development of new antiepileptic therapies that aim to prevent the epileptogenesis process or modify the progression of epilepsy in addition to treatment of epilepsy symptomatically. therefore, several investiga...

BACKGROUND Uncontrolled disease activity in inflammatory diseases of the joints, skin and bowel leads to morbidity and disability. Disease-modifying therapies are widely used to suppress this disease activity, but cost-coverage is variable. For Treaty First Nations and Inuit people in Canada without alternative private or public health insurance, cost-coverage for disease-modifying therapy is p...

The opinion of Russian experts on the possibility COVID-19 vaccination in patients with multiple sclerosis (MS) is presented. authors consensus, based an analysis a large number domestic and foreign guidelines, conclude that it possible to use killed inactivated vaccines. Preliminary recommendations are given for vaccination, taking into account MS disease modifying therapies.